1,517
Views
61
CrossRef citations to date
0
Altmetric
Review

Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery

, , &
Pages 1313-1327 | Received 13 May 2019, Accepted 23 Aug 2019, Published online: 20 Sep 2019
 

ABSTRACT

Introduction: Prediction of human absorption, distribution, metabolism, and excretion (ADME) properties, therapeutic dose and exposure has become an integral part of compound optimization in discovery. Incorporation of drug metabolism and pharmacokinetics into discovery projects has largely tempered historical drug failure due to sub-optimal ADME. In the current era, inadequate safety and efficacy are leading culprits for attrition; both of which are dependent upon drug exposure. Therefore, prediction of human pharmacokinetics (PK) and dose are core components of de-risking strategies in discovery.

Areas covered: The authors provide an overview of human dose prediction methods and present a toolbox of PK parameter prediction models with a proposed framework for a consensus approach valid throughout the discovery value chain. Mechanistic considerations and indicators for their application are discussed which may impact the dose prediction approach. Examples are provided to illustrate how implementation of the proposed strategy throughout discovery can assist project progression.

Expert opinion: Anticipation of human ADME, therapeutic dose and exposure must be deliberated throughout drug discovery from virtual/initial synthesis where key properties are considered and similar molecules ranked, into development where advanced compounds can be subject to prediction with greater mechanistic understanding and data-driven model selection.

Article highlights

  • Key parameters required to predict a clinically relevant oral dose are absorption (rate and extent), clearance, volume of distribution and target efficacious exposure

  • The judicious combination of these within a multi-parameter optimization tool can facilitate project telemetry

  • Clearance is the single most important parameter to optimize and predict successfully, as well as arguably being the most difficult to project in human with a high degree of confidence

  • Css,av model for dose prediction is a valid, pragmatic approach for early discovery given the minimal parameter burden. It should be considered for early ranking to make preliminary assessment within a compound series and identify areas for optimization

  • Maintaining unbound exposure above target efficacious concentration for the entire dosing interval is a cautious approach to dose prediction and has the greatest parameter burden and sensitivity

  • Mechanistic understanding is important in refining the prediction of human PK parameters and likely clinical dose with increased certainty for lead compounds when using advanced models

  • Consideration of human ADME properties and likely therapeutic dose remains a key goal for discovery projects, and should evolve in complexity from early in the discovery phase through to first time in man

This box summarizes key points contained in the article.

Declaration of interest

P Barton is the Vice President of Drug Metabolism and Pharmacokinetics and RJ Riley the Executive Vice President of Drug Metabolism and Pharmacokinetics at Evotec. JL Sproston and AJ Lucas are also employees of Evotec. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer Disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This manuscript was funded by Evotec.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,340.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.